Publicaciones (36) Publicaciones en las que ha participado algún/a investigador/a

2002

  1. A comparison of three antiemetic combinations for the prevention of postoperative nausea and vomiting

    Anesthesia and Analgesia, Vol. 95, Núm. 6, pp. 1590-1595

  2. Adaptive immune responses of legumin nanoparticles

    Journal of Drug Targeting, Vol. 10, Núm. 8, pp. 625-631

  3. Albumin nanoparticles as carriers for a phosphodiester oligonucleotide

    International Journal of Pharmaceutics, Vol. 244, Núm. 1-2, pp. 59-72

  4. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors

    European Journal of Pharmacology, Vol. 442, Núm. 1-2, pp. 63-71

  5. Capítulo 15: Integración y aplciaciones de los estudios de farmacoeconomía e investigación de reusktados en salud en los diferentes niveles asistenciales

    Farmacoeconomía e Investigación de resultados en la Salud: Principios y práctica (España: Real Academia Nacional de Farmacia), pp. 359-400

  6. Contribution to the study of ochratoxin A in Spanish wines

    Food Additives and Contaminants, Vol. 19, Núm. 11, pp. 1058-1064

  7. Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis

    International Journal of Pharmaceutics, Vol. 242, Núm. 1-2, pp. 341-344

  8. Efficacy of ganciclovir-loaded nanoparticles in human cytomegalovirus (HCMV)-infected cells

    Journal of Drug Targeting, Vol. 10, Núm. 3, pp. 231-238

  9. Enhanced gene delivery in vitro and in vivo by improved transferrin-lipoplexes

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1561, Núm. 2, pp. 209-221

  10. GABAA receptor antagonists enhance cortical acetylcholine release induced by 5-HT3 receptor blockade in freely moving rats

    Brain Research, Vol. 956, Núm. 1, pp. 81-85

  11. Gantrez® AN as a new polymer for the preparation of ligand-nanoparticle conjugates

    Journal of Controlled Release, Vol. 83, Núm. 3, pp. 321-330

  12. Implications of left bundle branch block in acute myocardial infarction treated with primary angioplasty

    American Journal of Cardiology, Vol. 90, Núm. 4, pp. 401-403

  13. In vitro antileishmanial activity of amphotericin B loaded in poly(ε-caprolactone) nanospheres

    Journal of Drug Targeting, Vol. 10, Núm. 8, pp. 593-599

  14. In vitro evaluation of gentamicin released from microparticles

    International Journal of Pharmaceutics, Vol. 242, Núm. 1-2, pp. 203-206

  15. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres

    European Journal of Pharmaceutical Sciences, Vol. 15, Núm. 2, pp. 197-207

  16. Induction of micronuclei in V79 cells after combined treatments with heterocyclic aromatic amines

    Food and Chemical Toxicology, Vol. 40, Núm. 10, pp. 1463-1467

  17. Investigaciones sobre las nuevas formas farmacéuticas como vehículo de medicamentos

    Anales de la Real Academia de Medicina y Cirugía de Valladolid, Núm. 40, pp. 261-284

  18. La píldora del día siguiente: aspectos farmacológicos, éticos y jurídicos

    Madrid : Sekotia, 2002

  19. Modeling of the sedative and airway obstruction effects of propofol in patients with Parkinson disease undergoing stereotactic surgery

    Anesthesiology, Vol. 97, Núm. 6, pp. 1378-1386

  20. Modulation of mutagenic activity in meat samples after deep-frying in vegetable oils

    Mutagenesis, Vol. 17, Núm. 1, pp. 63-66